Nanose Medical
PrivateLast Round
Grant
Jan 1, 2024
Total Funding Raised
$9.13M
Company Overview
Nanose Medical operates in Healthcare & Life Sciences and is based in Netanya. Its latest recorded funding round was a Grant round in January 2024.
Nanose Medical is a diagnostic equipment company that develops a portable, non-invasive sensing device designed to detect volatile biomarkers in breath for early screening of lung cancer and metabolic dysfunction-associated steatohepatitis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Sensors, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanose Medical Comparables
Compare Nanose Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| The eNose Company | 87% | |
| Noze | 83% | |
| Breathomix | 82% |
For institutional investors. Book with your work email.
Nanose Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2024 | ||||
| Grant | Nov 1, 2023 | ||||
| Grant | Sep 1, 2023 | ||||
| Grant | Jan 1, 2023 | ||||
| Seed | Jun 1, 2021 | ||||
Pre Seed | Nov 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nanose Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Israel Innovation Authority | Grant |
| Technion | Pre Seed |
| Horizon Europe | Grant |
| Technion Research & Development Foundation | Pre Seed, Seed |
| Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 3344% MoM, from 55 to 1.9K.
- Jan 20, 2026
Grew 50% QoQ, from 10 to 15 employees.
For institutional investors. Book with your work email.
Nanose Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanose Medical's valuation, stock price, and market status.
Is Nanose Medical a public or private company?
Nanose Medical is a private company.
What is the current stock price of Nanose Medical?
Nanose Medical is a private company, so its shares have no public market price. Caplight tracks Nanose Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanose Medical worth (valuation)?
Valuation information for Nanose Medical is not publicly available.
Can I buy Nanose Medical stock?
Nanose Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanose Medical's last funding round?
Nanose Medical's most recent funding round was Grant on January 1, 2024.
Who are the main investors in Nanose Medical?
Key investors in Nanose Medical include European Innovation Council Fund, Israel Innovation Authority, Technion, Horizon Europe, Technion Research & Development Foundation.
Will Nanose Medical IPO soon?
No public IPO plans have been announced for Nanose Medical.
How can I track Nanose Medical secondary market activity?
Caplight tracks bids, offers, and trades in Nanose Medical's shares on secondary markets.